Could Elekta's mystery new product help it grab market share from rival Varian?
This article was originally published in Clinica
Executive Summary
Radiotherapy specialist Elekta will be launching a new product that it describes as "the future of radiotherapy" on 1 March, prompting excitement among analysts. "While the company has yet to provide details about the new system, our due diligence suggests that it will likely be a state-of-the-art IGRT [image-guided radiotherapy] system, focused on the higher-end part of the market, and competitive vs [Varian Medical Systems'] TrueBeam," wrote Goldman Sachs' Veronika Dubajova.
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.